Jiangsu Only Three Biotechnology

Jiangsu Only Three Biotechnology (GeneIII) is a synthetic biology company established in August 2021, with its headquarters in Nanjing, Jiangsu. The company integrates research and development, production, and sales, positioning itself as a key international supplier of ergothioneine raw materials. GeneIII was founded by Chairman Ding Wei, who holds a Master's degree in Materials Engineering from the University of Science and Technology Beijing and another from the University of Nevada, USA. Before establishing GeneIII, Ding Wei had an extensive career, serving as a senior vice president at A.O. Smith Group and president of its China division, as well as CEO of Hengjie Group, accumulating over 20 original patents. The company was co-founded by Chief Scientist Dr. Wang Yang, who holds a Ph.D. in pharmacy from Oregon State University and has postdoctoral experience in biomedical science from UIUC.

The company's core business revolves around the production and supply of high-purity ergothioneine, a potent antioxidant used in the health and beauty industries. GeneIII employs synthetic biology techniques to achieve the engineering and mass production of this ingredient, reaching a purity of 99.99%. This production method, which the company likens to a "4x100-meter relay" race encompassing strain construction, fermentation, purification, and scaled-up production, has enabled a significant cost reduction, making ergothioneine more accessible. The business model involves supplying this raw material to various sectors and also developing its own consumer products under brands like "GeneIII" and "HA&EGT 玻麦妍". Their product line includes the high-purity ergothioneine raw material, ergothioneine capsules, and skincare products like serums and lotions. The company operates on a cGMP-compliant manufacturing platform, which allows for a monthly production capacity of up to 3 tons, sufficient to meet global market demands.

Since its inception, GeneIII has achieved notable milestones. Within two years, it successfully scaled the production of ergothioneine, drastically lowering its market price. The company has been recognized for its contributions, selected for CCTV's "Quality China" program and included in the "Industrial Value Gold List of Synthetic Biology" alongside established industry players. This rapid growth and technological achievement have attracted investors such as CITIC Group, HY Capital, and JAFCO Asia. GeneIII's strategy focuses on creating an "anti-aging ecosystem" centered around ergothioneine, exploring new applications, and developing composite formula products. The company aims to be more than just a raw material supplier by building a comprehensive synthetic biology platform. Keywords: Ergothioneine, synthetic biology, antioxidant, raw material supplier, skincare ingredients, nutraceuticals, cGMP manufacturing, fermentation, anti-aging, biotechnology, Ding Wei, Wang Yang, GeneIII, HA&EGT, Nanjing, biomanufacturing, cosmetic ingredients, health supplements, cell protection, industrial-scale production